Notificação de entrada na fase nacional - PCT
#1.3
10/17/2023
RPI 2754
Application data
Number
112023019034Type
Filing
Publication
PCT
EP2022057305 The application was filed at the INPI on 03/21/2022. It awaits formal examination and publication in the RPI gazette.
Latest action published by the INPI: 10/17/2023. We update with every new RPI gazette, published weekly.
Applicants
ASTRAZENECA AB
SE
Inventors
D. S. (pessoa física)
GB
H. R. (pessoa física)
CN
IPC Classification
Priority claims
CN
PCT/CN2021/081978 · 03/22/2021
Abstract
FORMULAÇÃO COMPREENDENDO CERALASERTIBE. A presente invenção refere-se a formulação farmacêutica que compreende ceralasertabe, fosfato de cálcio dibásico, celulose microcristalina, hidroxipropilcelulose de baixa substituição e estearato de magnésio.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
10/17/2023
RPI 2754
#1.1
10/03/2023
RPI 2752
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.